Skip to content

Hypoperfusion and activated protein C after out of hospital cardiac arrest: triggers for hyperfibrinolysis

Hypoperfusion and activated protein C after out of hospital cardiac arrest: triggers for hyperfibrinolysis - LYSIS-OHCA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37362
Enrollment
60
Registered
2012-08-14
Start date
2012-09-05
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest cardiopulmonary arrest

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients Admitted to shock room by paramedic ambulance (presence of registration files for cardiopulmonary resuscitation) Return of spontaneous circulation (ROSC) after out of hospital cardiac arrest Presence of hyperfibrinolysis

Exclusion criteria

Exclusion criteria: Patients with hemostatic deficiencies or previous hemostatic problems Deceased patients upon ED arrival Absence of a peripheral intravenous catheter Patients using vitamine K antagonists, clopidogrel or dabigatran

Design outcomes

Primary

MeasureTime frame
Main study parameter/endpoint: Hypoperfusion as reflected by cerebral tissue hemoglobin oxygenation and the incidence and onset time of hyperfibrinolysis in OHCA patients

Secondary

MeasureTime frame
Secondary study parameters/endpoints - Blood coagulation and fibrinolytic parameters. - Patient demographics including age, gender, body mass index, smoking. - Cause of out of hospital cardiac arrest. - Medication use - Time to cardiopulmonary resuscitation, duration of cardiopulmonary resuscitation, body temperature upon arrival. - Lowest temperature during post-resuscitation cooling, duration of cooling. - Mortality.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)